Evaluation of anti-tremor drugs in tremor-induced rodents.
D006916:5-Hydroxytryptophan / Q000633:toxicity*; D000470:Alkaloids / Q000633:toxicity*; D000605:Amino Alcohols / Q000633:toxicity*; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use*; D002714:Chlorisondamine / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000627:therapeutic use*; D002749:Chlorprothixene / Q000627:therapeutic use*; D007490:Iproniazid / Q000633:toxicity*; D008238:Lysergic Acid Diethylamide / Q000627:therapeutic use*; D008615:Mephenesin / Q000627:therapeutic use*; D051379:Mice; D009538:Nicotine / Q000633:toxicity*; D012601:Scopolamine / Q000627:therapeutic use*; D014202:Tremor / Q000188:drug therapy*; D014203:Tremorine / Q000633:toxicity*; D014293:Trimethadione
D000470:Alkaloids; D000605:Amino Alcohols; D000927:Anticonvulsants; D009538:Nicotine; D008615:Mephenesin; D008238:Lysergic Acid Diethylamide; D002749:Chlorprothixene; D006916:5-Hydroxytryptophan; D007490:Iproniazid; D012601:Scopolamine; D002714:Chlorisondamine; D014293:Trimethadione; D002746:Chlorpromazine; D014203:Tremorine